Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. East African-British Medical Research Councils.

× No keyword cloud information.

28 in total

1. Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy.

Authors: Jotam G Pasipanodya; Shashikant Srivastava; Tawanda Gumbo
Journal: Clin Infect Dis Date: 2012-03-30 Impact factor: 9.079

Review 2. Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.

Authors: Yusuke Minato; Joshua M Thiede; Shannon Lynn Kordus; Edward J McKlveen; Breanna J Turman; Anthony D Baughn
Journal: Antimicrob Agents Chemother Date: 2015-06-01 Impact factor: 5.191

Review 3. The Bewildering Antitubercular Action of Pyrazinamide.

Authors: Elise A Lamont; Nicholas A Dillon; Anthony D Baughn
Journal: Microbiol Mol Biol Rev Date: 2020-03-04 Impact factor: 11.056

Review 4. Therapeutic drug monitoring in the treatment of tuberculosis: an update.

Authors: Abdullah Alsultan; Charles A Peloquin
Journal: Drugs Date: 2014-06 Impact factor: 9.546

5. Tuberculosis, now and the future: short-term therapy, preventive therapy, and bacillus Calmette-Guérin.

Authors: P Q Edwards
Journal: Bull N Y Acad Med Date: 1977 Jul-Aug

6. Population Pharmacokinetics of Pyrazinamide in Patients with Tuberculosis.

Authors: Abdullah Alsultan; Rada Savic; Kelly E Dooley; Marc Weiner; William Whitworth; William R Mac Kenzie; Charles A Peloquin
Journal: Antimicrob Agents Chemother Date: 2017-05-24 Impact factor: 5.191

7. The case for short-course chemotherapy of pulmonary tuberculosis.

Authors: J H Angel
Journal: Drugs Date: 1983-07 Impact factor: 9.546

8. A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosets.

Authors: Laura E Via; Kathleen England; Danielle M Weiner; Daniel Schimel; Matthew D Zimmerman; Emmanuel Dayao; Ray Y Chen; Lori E Dodd; Mike Richardson; Katherine K Robbins; Ying Cai; Dima Hammoud; Peter Herscovitch; Véronique Dartois; JoAnne L Flynn; Clifton E Barry
Journal: Antimicrob Agents Chemother Date: 2015-05-04 Impact factor: 5.191

9. Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis.

Authors: Nicholas D Peterson; Brandon C Rosen; Nicholas A Dillon; Anthony D Baughn
Journal: Antimicrob Agents Chemother Date: 2015-09-14 Impact factor: 5.191

Review 10. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis.

Authors: Dick Menzies; Andrea Benedetti; Anita Paydar; Ian Martin; Sarah Royce; Madhukar Pai; Andrew Vernon; Christian Lienhardt; William Burman
Journal: PLoS Med Date: 2009-09-15 Impact factor: 11.069